HEADER TRANSFERASE 03-DEC-15 5F4N
TITLE MULTI-PARAMETER LEAD OPTIMIZATION TO GIVE AN ORAL CHK1 INHIBITOR
TITLE 2 CLINICAL CANDIDATE: (R)-5-((4-((MORPHOLIN-2-YLMETHYL)AMINO)-5-
TITLE 3 (TRIFLUOROMETHYL)PYRIDIN-2-YL)AMINO)PYRAZINE-2-CARBONITRILE
TITLE 4 (CCT245737)
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK1;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: CHK1 CHECKPOINT HOMOLOG,CELL CYCLE CHECKPOINT KINASE,
COMPND 5 CHECKPOINT KINASE-1;
COMPND 6 EC: 2.7.11.1;
COMPND 7 ENGINEERED: YES;
COMPND 8 OTHER_DETAILS: METHYL 6-[(5-CYANOPYRAZIN-2-YL)AMINO]-4-[(MORPHOLIN-2-
COMPND 9 YLMETHYL)AMINO]PYRIDINE-3-CARBOXYLATE
SOURCE MOL_ID: 1;
SOURCE 2 SYNTHETIC: YES;
SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 4 ORGANISM_COMMON: HUMAN;
SOURCE 5 ORGANISM_TAXID: 9606
KEYWDS INHIBITOR DNA-DAMAGE CHK1-POTENCY HERG-ACTIVITY, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR I.COLLINS,M.D.GARRETT,R.VAN MONTFORT,J.D.OSBORNE,T.P.MATTHEWS,
AUTHOR 2 T.MCHARDY,N.PROISY,K.J.CHEUNG,M.LAINCHBURY,N.BROWN,M.I.WALTON,
AUTHOR 3 P.D.EVE,K.J.BOXALL,A.HAYES,A.T.HENLEY,M.R.VALENTI,A.K.DE HAVEN
AUTHOR 4 BRANDON,G.BOX,I.M.WESTWOOD,Y.JAMIN,S.P.ROBINSON,P.LEONARD,
AUTHOR 5 J.C.READER,G.W.AHERNE,F.I.RAYNAUD,S.A.ECCLES
REVDAT 3 08-MAY-24 5F4N 1 REMARK
REVDAT 2 22-JUN-16 5F4N 1 JRNL
REVDAT 1 25-MAY-16 5F4N 0
JRNL AUTH J.D.OSBORNE,T.P.MATTHEWS,T.MCHARDY,N.PROISY,K.M.CHEUNG,
JRNL AUTH 2 M.LAINCHBURY,N.BROWN,M.I.WALTON,P.D.EVE,K.J.BOXALL,A.HAYES,
JRNL AUTH 3 A.T.HENLEY,M.R.VALENTI,A.K.DE HAVEN BRANDON,G.BOX,Y.JAMIN,
JRNL AUTH 4 S.P.ROBINSON,I.M.WESTWOOD,R.L.VAN MONTFORT,P.M.LEONARD,
JRNL AUTH 5 M.B.LAMERS,J.C.READER,G.W.AHERNE,F.I.RAYNAUD,S.A.ECCLES,
JRNL AUTH 6 M.D.GARRETT,I.COLLINS
JRNL TITL MULTIPARAMETER LEAD OPTIMIZATION TO GIVE AN ORAL CHECKPOINT
JRNL TITL 2 KINASE 1 (CHK1) INHIBITOR CLINICAL CANDIDATE:
JRNL TITL 3 (R)-5-((4-((MORPHOLIN-2-YLMETHYL)AMINO)-5-(TRIFLUOROMETHYL)
JRNL TITL 4 PYRIDIN-2-YL)AMINO)PYRAZINE-2-CARBONITRILE (CCT245737).
JRNL REF J.MED.CHEM. V. 59 5221 2016
JRNL REFN ISSN 0022-2623
JRNL PMID 27167172
JRNL DOI 10.1021/ACS.JMEDCHEM.5B01938
REMARK 2
REMARK 2 RESOLUTION. 1.91 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.10.2
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.91
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.54
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 82.2
REMARK 3 NUMBER OF REFLECTIONS : 21580
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.151
REMARK 3 R VALUE (WORKING SET) : 0.149
REMARK 3 FREE R VALUE : 0.188
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820
REMARK 3 FREE R VALUE TEST SET COUNT : 1040
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 11
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.91
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.00
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 28.12
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 979
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1986
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 934
REMARK 3 BIN R VALUE (WORKING SET) : 0.1985
REMARK 3 BIN FREE R VALUE : 0.2001
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 45
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2027
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 72
REMARK 3 SOLVENT ATOMS : 313
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 22.35
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.42
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.46170
REMARK 3 B22 (A**2) : -2.14970
REMARK 3 B33 (A**2) : 1.68790
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -0.12190
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.179
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.152
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.135
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.138
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.129
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 2186 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 2961 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 748 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 51 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 347 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 2186 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 272 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : 7 ; 1.000 ; HARMONIC
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 2834 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 0.98
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.11
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.13
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 3
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: {A|3 - 61}
REMARK 3 ORIGIN FOR THE GROUP (A): 9.0710 -2.4287 4.0277
REMARK 3 T TENSOR
REMARK 3 T11: 0.0652 T22: 0.0689
REMARK 3 T33: -0.1068 T12: -0.0669
REMARK 3 T13: -0.0195 T23: -0.0474
REMARK 3 L TENSOR
REMARK 3 L11: 0.1593 L22: 0.0000
REMARK 3 L33: 3.9388 L12: -1.3602
REMARK 3 L13: -0.7999 L23: 1.3167
REMARK 3 S TENSOR
REMARK 3 S11: -0.0051 S12: 0.2717 S13: -0.0037
REMARK 3 S21: -0.0360 S22: -0.0144 S23: 0.2454
REMARK 3 S31: 0.4425 S32: -0.2188 S33: 0.0195
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 SELECTION: {A|62 - 255}
REMARK 3 ORIGIN FOR THE GROUP (A): 15.6060 2.5062 27.0182
REMARK 3 T TENSOR
REMARK 3 T11: -0.0781 T22: -0.1050
REMARK 3 T33: -0.0689 T12: 0.0108
REMARK 3 T13: 0.0006 T23: 0.0019
REMARK 3 L TENSOR
REMARK 3 L11: 2.4774 L22: 1.3901
REMARK 3 L33: 1.1065 L12: 0.4655
REMARK 3 L13: -0.3601 L23: -0.0481
REMARK 3 S TENSOR
REMARK 3 S11: -0.0583 S12: 0.0095 S13: -0.1119
REMARK 3 S21: -0.0772 S22: -0.0054 S23: -0.0388
REMARK 3 S31: 0.0506 S32: -0.0346 S33: 0.0636
REMARK 3
REMARK 3 TLS GROUP : 3
REMARK 3 SELECTION: {A|256 - 271}
REMARK 3 ORIGIN FOR THE GROUP (A): 22.4617 17.8610 30.3574
REMARK 3 T TENSOR
REMARK 3 T11: -0.0414 T22: -0.0684
REMARK 3 T33: 0.0571 T12: 0.0160
REMARK 3 T13: -0.0017 T23: -0.0185
REMARK 3 L TENSOR
REMARK 3 L11: -0.0737 L22: 4.9768
REMARK 3 L33: 1.4967 L12: 2.4706
REMARK 3 L13: 0.3879 L23: -1.8631
REMARK 3 S TENSOR
REMARK 3 S11: -0.0226 S12: -0.0137 S13: 0.3652
REMARK 3 S21: 0.0982 S22: -0.1673 S23: -0.1212
REMARK 3 S31: -0.1214 S32: -0.0505 S33: 0.1899
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5F4N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-DEC-15.
REMARK 100 THE DEPOSITION ID IS D_1000215990.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 30-JAN-08
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21594
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.910
REMARK 200 RESOLUTION RANGE LOW (A) : 26.540
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 82.4
REMARK 200 DATA REDUNDANCY : 2.800
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 54.73
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.72
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350 DL-MALIC ACID, VAPOR
REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291.15K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.93500
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1220 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 12640 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 10.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 1
REMARK 465 ALA A 2
REMARK 465 VAL A 3
REMARK 465 PRO A 4
REMARK 465 MET A 42
REMARK 465 LYS A 43
REMARK 465 ARG A 44
REMARK 465 ALA A 45
REMARK 465 VAL A 46
REMARK 465 ASP A 47
REMARK 465 CYS A 48
REMARK 465 PRO A 49
REMARK 465 GLU A 50
REMARK 465 GLY A 272
REMARK 465 ALA A 273
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 GLU A 7 CG CD OE1 OE2
REMARK 470 ASP A 8 CG OD1 OD2
REMARK 470 GLU A 17 CG CD OE1 OE2
REMARK 470 TYR A 20 CG CD1 CD2 CE1 CE2 CZ OH
REMARK 470 GLU A 22 CG CD OE1 OE2
REMARK 470 GLN A 24 CD OE1 NE2
REMARK 470 ASP A 41 CG OD1 OD2
REMARK 470 ASN A 51 CG OD1 ND2
REMARK 470 LYS A 53 CG CD CE NZ
REMARK 470 LYS A 60 CE NZ
REMARK 470 ARG A 74 CG CD NE CZ NH1 NH2
REMARK 470 ARG A 75 CG CD NE CZ NH1 NH2
REMARK 470 GLU A 76 CG CD OE1 OE2
REMARK 470 ASN A 78 CG OD1 ND2
REMARK 470 ILE A 79 CG1 CG2 CD1
REMARK 470 ARG A 141 NE CZ NH1 NH2
REMARK 470 LYS A 166 CG CD CE NZ
REMARK 470 LYS A 180 CD CE NZ
REMARK 470 LYS A 232 CD CE NZ
REMARK 470 LYS A 271 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASN A 63 88.53 -154.46
REMARK 500 ASP A 99 -1.21 71.33
REMARK 500 ARG A 129 -3.12 72.96
REMARK 500 ASP A 130 48.19 -148.52
REMARK 500 ASP A 130 48.19 -148.50
REMARK 500 ASP A 148 104.21 63.44
REMARK 500 ASN A 165 -15.49 -141.75
REMARK 500
REMARK 500 REMARK: NULL
REMARK 610
REMARK 610 MISSING HETEROATOM
REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 610 I=INSERTION CODE):
REMARK 610 M RES C SSEQI
REMARK 610 5UY A 302
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 5UY A 301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 5UY A 302
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 303
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 304
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 305
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 306
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 307
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 308
DBREF 5F4N A 1 273 UNP O14757 CHK1_HUMAN 1 273
SEQRES 1 A 273 MET ALA VAL PRO PHE VAL GLU ASP TRP ASP LEU VAL GLN
SEQRES 2 A 273 THR LEU GLY GLU GLY ALA TYR GLY GLU VAL GLN LEU ALA
SEQRES 3 A 273 VAL ASN ARG VAL THR GLU GLU ALA VAL ALA VAL LYS ILE
SEQRES 4 A 273 VAL ASP MET LYS ARG ALA VAL ASP CYS PRO GLU ASN ILE
SEQRES 5 A 273 LYS LYS GLU ILE CYS ILE ASN LYS MET LEU ASN HIS GLU
SEQRES 6 A 273 ASN VAL VAL LYS PHE TYR GLY HIS ARG ARG GLU GLY ASN
SEQRES 7 A 273 ILE GLN TYR LEU PHE LEU GLU TYR CYS SER GLY GLY GLU
SEQRES 8 A 273 LEU PHE ASP ARG ILE GLU PRO ASP ILE GLY MET PRO GLU
SEQRES 9 A 273 PRO ASP ALA GLN ARG PHE PHE HIS GLN LEU MET ALA GLY
SEQRES 10 A 273 VAL VAL TYR LEU HIS GLY ILE GLY ILE THR HIS ARG ASP
SEQRES 11 A 273 ILE LYS PRO GLU ASN LEU LEU LEU ASP GLU ARG ASP ASN
SEQRES 12 A 273 LEU LYS ILE SER ASP PHE GLY LEU ALA THR VAL PHE ARG
SEQRES 13 A 273 TYR ASN ASN ARG GLU ARG LEU LEU ASN LYS MET CYS GLY
SEQRES 14 A 273 THR LEU PRO TYR VAL ALA PRO GLU LEU LEU LYS ARG ARG
SEQRES 15 A 273 GLU PHE HIS ALA GLU PRO VAL ASP VAL TRP SER CYS GLY
SEQRES 16 A 273 ILE VAL LEU THR ALA MET LEU ALA GLY GLU LEU PRO TRP
SEQRES 17 A 273 ASP GLN PRO SER ASP SER CYS GLN GLU TYR SER ASP TRP
SEQRES 18 A 273 LYS GLU LYS LYS THR TYR LEU ASN PRO TRP LYS LYS ILE
SEQRES 19 A 273 ASP SER ALA PRO LEU ALA LEU LEU HIS LYS ILE LEU VAL
SEQRES 20 A 273 GLU ASN PRO SER ALA ARG ILE THR ILE PRO ASP ILE LYS
SEQRES 21 A 273 LYS ASP ARG TRP TYR ASN LYS PRO LEU LYS LYS GLY ALA
HET 5UY A 301 27
HET 5UY A 302 17
HET EDO A 303 4
HET EDO A 304 4
HET EDO A 305 4
HET EDO A 306 4
HET GOL A 307 6
HET GOL A 308 6
HETNAM 5UY METHYL 6-[(5-CYANOPYRAZIN-2-YL)AMINO]-4-[[(2~{R})-
HETNAM 2 5UY MORPHOLIN-2-YL]METHYLAMINO]PYRIDINE-3-CARBOXYLATE
HETNAM EDO 1,2-ETHANEDIOL
HETNAM GOL GLYCEROL
HETSYN EDO ETHYLENE GLYCOL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 2 5UY 2(C17 H19 N7 O3)
FORMUL 4 EDO 4(C2 H6 O2)
FORMUL 8 GOL 2(C3 H8 O3)
FORMUL 10 HOH *313(H2 O)
HELIX 1 AA1 ILE A 52 LEU A 62 1 11
HELIX 2 AA2 PHE A 93 ILE A 96 5 4
HELIX 3 AA3 PRO A 103 ILE A 124 1 22
HELIX 4 AA4 LYS A 132 GLU A 134 5 3
HELIX 5 AA5 THR A 170 VAL A 174 5 5
HELIX 6 AA6 ALA A 175 ARG A 181 1 7
HELIX 7 AA7 HIS A 185 GLY A 204 1 20
HELIX 8 AA8 CYS A 215 GLU A 223 1 9
HELIX 9 AA9 PRO A 230 ILE A 234 5 5
HELIX 10 AB1 ASP A 235 LEU A 246 1 12
HELIX 11 AB2 THR A 255 LYS A 260 1 6
SHEET 1 AA1 5 TRP A 9 GLU A 17 0
SHEET 2 AA1 5 GLU A 22 ASN A 28 -1 O VAL A 27 N ASP A 10
SHEET 3 AA1 5 ALA A 34 VAL A 40 -1 O VAL A 37 N GLN A 24
SHEET 4 AA1 5 ILE A 79 LEU A 84 -1 O LEU A 84 N ALA A 36
SHEET 5 AA1 5 PHE A 70 GLU A 76 -1 N ARG A 74 O TYR A 81
SHEET 1 AA2 3 GLY A 90 GLU A 91 0
SHEET 2 AA2 3 LEU A 136 LEU A 138 -1 O LEU A 138 N GLY A 90
SHEET 3 AA2 3 LEU A 144 ILE A 146 -1 O LYS A 145 N LEU A 137
SHEET 1 AA3 2 ILE A 126 THR A 127 0
SHEET 2 AA3 2 THR A 153 VAL A 154 -1 O THR A 153 N THR A 127
SHEET 1 AA4 2 ARG A 156 TYR A 157 0
SHEET 2 AA4 2 ARG A 160 GLU A 161 -1 O ARG A 160 N TYR A 157
CISPEP 1 ASN A 229 PRO A 230 0 1.30
SITE 1 AC1 15 LEU A 15 ALA A 36 LYS A 38 VAL A 68
SITE 2 AC1 15 LEU A 84 GLU A 85 TYR A 86 CYS A 87
SITE 3 AC1 15 SER A 88 GLU A 91 GLU A 134 LEU A 137
SITE 4 AC1 15 SER A 147 ASP A 148 HOH A 521
SITE 1 AC2 6 TRP A 9 VAL A 35 VAL A 37 TYR A 71
SITE 2 AC2 6 PHE A 83 HOH A 590
SITE 1 AC3 4 LEU A 179 SER A 212 ASP A 213 HOH A 478
SITE 1 AC4 3 GLY A 123 ARG A 156 HOH A 482
SITE 1 AC5 4 ASP A 209 SER A 212 SER A 214 CYS A 215
SITE 1 AC6 4 LEU A 206 TRP A 208 ASP A 209 HOH A 428
SITE 1 AC7 6 TRP A 221 LYS A 224 HIS A 243 LEU A 246
SITE 2 AC7 6 HOH A 416 HOH A 491
SITE 1 AC8 8 PHE A 93 ILE A 96 PRO A 133 TYR A 173
SITE 2 AC8 8 GLY A 204 GLU A 205 LEU A 206 HOH A 596
CRYST1 44.970 65.870 57.900 90.00 94.69 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.022237 0.000000 0.001824 0.00000
SCALE2 0.000000 0.015181 0.000000 0.00000
SCALE3 0.000000 0.000000 0.017329 0.00000